The MHRA has published new regulatory guidance clarifying how microbiome-based medicinal products can progress towards UK licensing. Teva Pharmaceuticals...
Read MoreNHS England has recommended routine commissioning of delayed-release mercaptamine bitartrate for eligible patients aged one year and above with...
Read MoreBeOne Medicines has secured a UK Innovation Passport for investigational bispecific antibody BGB-B2033 in advanced or metastatic hepatocellular carcinoma....
Read MoreAtsena Therapeutics has secured European orphan designation for two gene therapy candidates targeting rare inherited retinal diseases. Infinitopes has...
Read MoreLundbeck has secured FDA Fast Track designation for Lu AH69593, an oral orexin 2 receptor agonist being developed for...
Read MoreNICE has issued final draft guidance recommending Bayer’s finerenone for adults with symptomatic chronic heart failure and a left...
Read More